好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Sensorineural Hearing Loss From Capnocytophaga canimorsus Meningitis in an Immunocompetent Patient
Infectious Disease
P2 - Poster Session 2 (11:45 AM-12:45 PM)
13-004
NA

Capnocytophaga canimorsus, a gram-negative rod found in the oral flora of dogs and cats, is an extremely rare cause of bacterial meningitis. It is more frequently observed in immunocompromised individuals and diagnosis is often delayed due to its slow growth on culture media.

NA

A 38-year-old female presented with 2 days history of worsening headache, nausea, and bilateral hearing loss.  Neurological exam was only notable for bilateral hearing loss. Cerebrospinal fluid (CSF) studies revealed significantly elevated WBCs (4,612/cmm) with 79% neutrophils, elevated protein (348mg/dL), and low glucose (<1mg/dL), consistent with bacterial meningitis. Vancomycin and ceftriaxone were initiated. Blood and CSF cultures returned growing C. canimorsus and she was continued on ceftriaxone. MRI brain was unremarkable. She denied being bitten by her dogs and cat but was potentially scratched and licked by her dogs. On day 4 of presentation, otolaryngology and neurology were consulted for worsening hearing loss. She was started on a trial of methylprednisolone 60 mg daily for 5 days.  MRA head did not show any aneurysm and CT temporal bone did not exhibit signs of fibrosis. HIV antibody testing was negative. Audiogram demonstrated precipitous sloping indicating severe bilateral hearing loss. She completed a 15-day steroid taper with mild improvement in hearing. Repeat audiogram in 3 months showed improvement in higher frequencies and patient reports subjective improvement of her hearing.

We describe the case of a young immunocompetent woman who developed severe bilateral sensorineural hearing loss due to C. canimorsus meningitis. While early initiation of steroids in patients with pneumococcal meningitis is known to be associated with reduced risk of post-meningeal hearing loss, its utility in patients with C. canimorsus meningitis is unknown. This is the first case of steroid use in C. canimorsus meningitis with reported improvement in hearing, suggesting a potential therapeutic benefit to these patients.


Authors/Disclosures
Manny Villar
PRESENTER
Mr. Villar has nothing to disclose.
Cleo Zarina A. Reyes, MD (OhioHealth Physician Group) Dr. Reyes has nothing to disclose.
Ajay Menon, MD (Lehigh Valley Health Network) Dr. Menon has nothing to disclose.
Erafat Rehim, MD (LVHN) Dr. Rehim has nothing to disclose.
Gary W. Clauser, MD (Lehigh Neurology) Dr. Clauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bigoen . The institution of Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech . Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genzyme. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartid.